(Q35880384)

10 August 2017

1 reference

title

Review article: bone disease in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

10 August 2017

main subject

0 references

1 reference

Schulte CM

1

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

Alimentary Pharmacology & Therapeutics

10 August 2017

published in

1 reference

10 August 2017

volume

20 Suppl 4

1 reference

10 August 2017

page(s)

43-49

1 reference

AGA technical review on osteoporosis in gastrointestinal diseases.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02057.X

Osteoporosis in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02057.X

Fracture risk is increased in Crohn's disease, but not in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02057.X

The association between corticosteroid use and development of fractures among IBD patients in a population-based database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02057.X

Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02057.X

Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02057.X

Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02057.X

New steroids for IBD: progress report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02057.X

Bone density in a population-based cohort of premenopausal adult women with early onset inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02057.X

10.1111/J.1365-2036.2004.02057.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference